Journal Article

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2

Levy-Lahad, Ephrat, Renbaum, Paul, Beeri, Rachel, Gabai-Kapara, Efrat, Lahad, Amnon, Friedman, Eitan, Catane, Raphael, Beller, Uziel, Lee, Ming K., King, Mary-Claire, Mandell, Jessica B., Grinshpun-Cohen, Julia, Kaufman, Bella, Segev, Shlomo, Djemal, Karen, Gal, Moran

2014

Overview

In the Ashkenazi Jewish (AJ) population of Israel, 11% of breast cancer and 40% of ovarian cancer are due to three inherited founder mutations in the cancer predisposition genes BRCA1 and BRCA2 . For carriers of these mutations, risk-reducing salpingo-oophorectomy significantly reduces morbidity and mortality. Population screening for these mutations among AJ women may be justifiable if accurate estimates of cancer risk for mutation carriers can be obtained. We therefore undertook to determine risks of breast and ovarian cancer for BRCA1 and BRCA2 mutation carriers ascertained irrespective of personal or family history of cancer. Families harboring mutations in BRCA1 or BRCA2 were ascertained by identifying mutation carriers among healthy AJ males recruited from health screening centers and outpatient clinics. Female relatives of the carriers were then enrolled and genotyped. Among the female relatives with BRCA1 or BRCA2 mutations, cumulative risk of developing either breast or ovarian cancer by age 60 and 80, respectively, were 0.60 (± 0.07) and 0.83 (± 0.07) for BRCA1 carriers and 0.33 (± 0.09) and 0.76 (± 0.13) for BRCA2 carriers. Risks were higher in recent vs. earlier birth cohorts ( P = 0.006). High cancer risks in BRCA1 or BRCA2 mutation carriers identified through healthy males provide an evidence base for initiating a general screening program in the AJ population. General screening would identify many carriers who are not evaluated by genetic testing based on family history criteria. Such a program could serve as a model to investigate implementation and outcomes of population screening for genetic predisposition to cancer in other populations. Significance Inherited mutations in the tumor suppressor genes BRCA1 and BRCA2 predispose to very high risks of breast and ovarian cancer. For carriers of these mutations, risk-reducing surgery significantly reduces morbidity and mortality. General population screening for BRCA1 and BRCA2 mutations in young adult women could be feasible if accurate estimates of cancer risk for mutation carriers could be obtained. We determined that risks of breast and ovarian cancer for BRCA1 and BRCA2 mutation carriers ascertained from the general population are as high as for mutation carriers ascertained through personal or family history of cancer. General screening of BRCA1 and BRCA2 would identify many carriers who are currently not evaluated and could serve as a model for population screening for genetic predisposition to cancer.

• Publisher: National Academy of Sciences,National Acad Sciences
• Subject: Adult / Aged / Aged, 80 and over / animal ovaries / Biological Sciences / Breast cancer / Breast Neoplasms - epidemiology / Breast Neoplasms - genetics / Cancer / Cancer screening / Family history / Female / Females / Genes, BRCA1 / Genes, BRCA2 / Genetic Carrier Screening / Genetic counseling / Genetic mutation / Genetic Predisposition to Disease / Genetic screening / Genetic Testing - methods / Genetics / Genetics, Population / Health risks / Humans / Israel - epidemiology / Jews - genetics / Male / Medical genetics / Medical screening / Middle Aged / morbidity / Mortality / Mutation / Ovarian cancer / ovarian neoplasms / Ovarian Neoplasms - epidemiology / Ovarian Neoplasms - genetics / Population genetics / risk / Risk assessment / Risk Factors / Risk reduction / screening / Statistics / Subject indexing / surgery / tumor suppressor genes / tumor suppressor proteins / women / Womens health / young adults